Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Concorde Specialty Gases is a specialized supplier of high-purity gases, most notably Sulfur Hexafluoride (SF6), serving the electrical, electronics, and healthcare industries. Within the life sciences sector, the company provides medical-grade gases used in ophthalmic procedures, such as retinal reattachment surgery, as well as high-purity gases for laboratory and analytical applications. Founded in 1996 and headquartered in New Jersey, the company also offers gas recycling and management services to promote environmental sustainability. In 2014, Concorde was acquired by Airgas, becoming part of the Air Liquide group, which expanded its distribution and technical capabilities. The company is recognized for its expertise in gas purification and its ability to meet stringent quality standards for sensitive medical and industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Concorde Specialty Gases.